Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Clinical trial NCT06425198 · COMPLETED
Trial details
- NCT number
- NCT06425198
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2024-12-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.